Cargando…
Upregulation of SATB1 is associated with the development and progression of glioma
BACKGROUND: Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be expressed in several human cancers and may have malignant potential. This study was aimed at investigating the expression and potential role of SATB1 in human glioma. METHOD: The relationship between SATB1 express...
Autores principales: | Chu, Sheng-Hua, Ma, Yan-Bin, Feng, Dong-Fu, Zhang, Hong, Zhu, Zhi-An, Li, Zhi-Qiang, Jiang, Pu-Cha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492129/ https://www.ncbi.nlm.nih.gov/pubmed/22839214 http://dx.doi.org/10.1186/1479-5876-10-149 |
Ejemplares similares
-
Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma
por: Chu, Sheng-Hua, et al.
Publicado: (2011) -
Phosphorylated SATB1 is associated with the progression and prognosis of glioma
por: Han, S, et al.
Publicado: (2013) -
Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression
por: Shukla, Sanjeev, et al.
Publicado: (2013) -
Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo
por: Chu, Sheng-Hua, et al.
Publicado: (2012) -
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy
por: Chu, Sheng-Hua, et al.
Publicado: (2013)